StockData
Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc. (ORGO) stock

ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$0.81+0.01 (+1.06%)

Close on Nov 17, 2026Market cap $104.43MP/E –Yield –

Organogenesis total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Organogenesis's total debt was $49.63M at Dec 31, 2019. For fiscal 2019 it was $49.63M, up 294.6% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2019Dec 31, 2019$49.63M+294.6%
FY2018Dec 31, 2018$12.58M-15.1%
FY2017Dec 31, 2017$14.82M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2019Dec 31, 2019$49.63M+235.0%
Q2 FY2019Jun 30, 2019$39.66M–
Q1 FY2019Mar 31, 2019$39.64M–
Q4 FY2018Dec 31, 2018$12.58M–
Q4 FY2017Dec 31, 2017$14.82M–

More Organogenesis figures

See a number that looks wrong?